Springer Health+ IME

Watch our free, on-demand, CME-accredited symposium and explore how the tumor microenvironment shapes MF‑CTCL progression and what this means for clinical decision‑making. Register your interest for the on-demand webcast, available from April 2026: go.sn.pub/bxa459

We’re at #ATTD2026!📍 Visit us at booth 46 to explore our CME-accredited Ketone Monitoring Masterclass and test your knowledge on the latest in ketone monitoring for a chance to win an Amazon gift card. Start your learning in our expert-led program now: go.sn.pub/crvv1x

That's a wrap on #ECR2026! What a great congress, filled with fantastic insights. Not ready to move on yet? Head to our site to see daily summaries, expert insights, as well as a full news round-up coming soon: …trast-agents.ime.springermedicine.com/?utm_source=x&…

@Andrea_Vanzulli 🫡 And that’s our final #ECR2026 #Medthread. More coverage from the meeting will be coming soon on our site: …trast-agents.ime.springermedicine.com/?utm_source=x&…

@Andrea_Vanzulli 💡She suggested an imaging strategy for this patient group, including contrast-enhanced localized MRI for assessment of new symptomatic plexiform neurofibromas.

👋 Welcome to our fourth and final #Medthread from #ECR2026! It’s been a great meeting for GBCA information, and we’re delighted to share the last few MRI presentations on cardiac imaging, AI in pediatrics, and neuroendocrine tumors. #medtwitter #RadiologyTwitter

@chris_laustsen 🫡 We hope you’ve enjoyed these sessions. We’ll be back tomorrow for our fourth and final #Medthread from #ECR2026. Looking for key coverage and expert insights from the congress? Visit our website to find out more: …trast-agents.ime.springermedicine.com/?utm_source=x&…

@chris_laustsen He reported that DSC and ASL are “both valid sequences” that complement each other and while ASL needs “further optimization,” he hopes that it may offer an alternative to DSC when contrast is contraindicated.

👋 Welcome to our third #Medthread from #ECR2026! The week is certainly passing fast in sunny Vienna, and the great presentations keep on coming. Today’s highlights include an educational session on high-relaxivity GBCAs, and research presentations on the next-generation agents